Chad Armstrong is a successful entrepreneur with a passion for devising novel solutions to challenging problems. Holding both an engineering degree from McGill University and an MBA from INSEAD, Chad has extensive experience in leadership positions. In 2012, he co-founded Evinance, an industry-leading clinical decision support company focused on improving the quality of care for cancer patients. As the CEO, he designed the strategies and led the development and commercialization of their platform until 2018 when it was acquired by Varian. Following the acquisition, Chad led Varian’s clinical decision support initiatives as Director of Product Management.
Current role